Literature DB >> 10680042

Influence of the HDL receptor SR-BI on atherosclerosis.

M Krieger1, K Kozarsky.   

Abstract

The scavenger receptor class B, type I (SR-BI) is an HDL receptor that mediates selective cholesterol uptake from HDL to cells. In rodents, SR-BI has a critical influence on plasma HDL-cholesterol concentration and structure, the delivery of cholesterol to steroidogenic tissues, female fertility, and biliary cholesterol concentration. SR-BI can also serve as a receptor for non-HDL lipoproteins and appears to play an important role in reverse cholesterol transport. Recent studies involving the manipulation of SR-BI expression in mice, either using adenovirus-mediated or transgenic hepatic overexpression or using homologous recombination for complete functional ablation, indicate that the expression of SR-BI protects against atherosclerosis. If SR-BI has a similar activity in humans, it may become an attractive target for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10680042     DOI: 10.1097/00041433-199912000-00003

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  14 in total

1.  Procollagen C-endopeptidase Enhancer Protein 2 (PCPE2) Reduces Atherosclerosis in Mice by Enhancing Scavenger Receptor Class B1 (SR-BI)-mediated High-density Lipoprotein (HDL)-Cholesteryl Ester Uptake.

Authors:  Ricquita D Pollard; Christopher N Blesso; Manal Zabalawi; Brian Fulp; Mark Gerelus; Xuewei Zhu; Erica W Lyons; Nebil Nuradin; Omar L Francone; Xiang-An Li; Daisy Sahoo; Michael J Thomas; Mary G Sorci-Thomas
Journal:  J Biol Chem       Date:  2015-05-06       Impact factor: 5.157

2.  Negatively cooperative binding of high-density lipoprotein to the HDL receptor SR-BI.

Authors:  Thomas J F Nieland; Shangzhe Xu; Marsha Penman; Monty Krieger
Journal:  Biochemistry       Date:  2011-02-25       Impact factor: 3.162

Review 3.  Human ocular carotenoid-binding proteins.

Authors:  Binxing Li; Preejith Vachali; Paul S Bernstein
Journal:  Photochem Photobiol Sci       Date:  2010-09-03       Impact factor: 3.982

4.  Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI.

Authors:  Manojkumar Valiyaveettil; Niladri Kar; Mohammad Z Ashraf; Tatiana V Byzova; Maria Febbraio; Eugene A Podrez
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

5.  Influence of PDZK1 on lipoprotein metabolism and atherosclerosis.

Authors:  Olivier Kocher; Ayce Yesilaltay; Ching-Hung Shen; Songwen Zhang; Kathleen Daniels; Rinku Pal; Jianzhu Chen; Monty Krieger
Journal:  Biochim Biophys Acta       Date:  2008-03-10

Review 6.  Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BI.

Authors:  Olivier Kocher; Monty Krieger
Journal:  Curr Opin Lipidol       Date:  2009-06       Impact factor: 4.776

7.  Influence of aspirin on SR-BI expression in human carotid plaques.

Authors:  Andreas Wehinger; Ivan Tancevski; Ruediger Seiler; Sandra M Frotschnig; Stefan Frantz; Julia Huber; Philipp Eller; Wilfried Schgoer; Bernhard Foeger; Josef R Patsch; Andreas Ritsch
Journal:  Atherosclerosis       Date:  2009-02-03       Impact factor: 5.162

8.  Kimchi methanol extract and the kimchi active compound, 3'-(4'-hydroxyl-3',5'-dimethoxyphenyl)propionic acid, downregulate CD36 in THP-1 macrophages stimulated by oxLDL.

Authors:  Ye-Rang Yun; Hyun-Ju Kim; Yeong-Ok Song
Journal:  J Med Food       Date:  2014-07-10       Impact factor: 2.786

9.  Apolipoprotein A-I but not high-density lipoproteins are internalised by RAW macrophages: roles of ATP-binding cassette transporter A1 and scavenger receptor BI.

Authors:  Iris Lorenzi; Arnold von Eckardstein; Clara Cavelier; Silvija Radosavljevic; Lucia Rohrer
Journal:  J Mol Med (Berl)       Date:  2007-10-01       Impact factor: 4.599

Review 10.  Role of scavenger receptors in glia-mediated neuroinflammatory response associated with Alzheimer's disease.

Authors:  Francisca Cornejo; Rommy von Bernhardi
Journal:  Mediators Inflamm       Date:  2013-05-07       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.